Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)

SHA:600671 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	70.11	31.89	65.72	97.96	42.39	22.29
Cash & Short-Term Investments	70.11	31.89	65.72	97.96	42.39	22.29
Cash Growth	176.37%	-51.48%	-32.91%	131.09%	90.18%	194.31%
Accounts Receivable	124.54	146.69	97.97	36.96	30.99	51.83
Other Receivables	1.52	1.34	2.56	2	1.79	54.92
Receivables	126.07	148.03	100.54	38.96	32.78	106.75
Inventory	38.61	39.18	52.32	42.95	47.56	52.36
Prepaid Expenses	-	-	-	-	0.03	-
Other Current Assets	8.94	9.37	4.13	1.63	1.37	4.68
Total Current Assets	243.72	228.48	222.71	181.5	124.13	186.08
Property, Plant & Equipment	189.93	193.85	192.86	151.66	164.94	199.82
Goodwill	1.61	1.61	1.61	2.2	2.2	3.31
Other Intangible Assets	4.93	5.01	5.09	5.21	5.37	5.52
Long-Term Deferred Tax Assets	8.54	9.86	7.14	3.51	3.45	1.98
Long-Term Deferred Charges	3.28	3.16	12.05	2.2	2.48	5.93
Other Long-Term Assets	0.06	0.06	-	-	-	-
Total Assets	452.07	442.03	441.46	346.29	302.57	402.65

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	70.21	60.75	58.35	44.71	35.92	48.97
Accrued Expenses	3.45	12.64	14.24	12.6	15.13	13.92
Short-Term Debt	171.87	144.3	128.91	102.94	105.14	108.15
Current Portion of Long-Term Debt	7.34	-	-	-	-	-
Current Portion of Leases	-	12.84	13.11	4.44	3.44	1
Current Income Taxes Payable	6.28	4.39	10.44	3.02	0.3	0.66
Current Unearned Revenue	3.28	3.35	2.45	3.39	3.58	2.99
Other Current Liabilities	27.64	44.16	58.88	49.28	57.71	75.45
Total Current Liabilities	290.07	282.42	286.38	220.38	221.22	251.15
Long-Term Leases	10.56	8.65	10.34	7.23	7.46	4.55
Long-Term Unearned Revenue	43.69	46.65	52.63	58.62	65.25	78.71
Long-Term Deferred Tax Liabilities	6.65	7.96	6.14	2.97	2.65	-
Other Long-Term Liabilities	2.18	2.36	0.95	1.15	1.43	3.68
Total Liabilities	353.14	348.04	356.44	290.34	298.01	338.09

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	121.78	121.78	121.78	121.78	121.78	121.78
Additional Paid-In Capital	162.79	162.79	162.79	162.79	72.79	65.04
Retained Earnings	-208.26	-214.56	-232.18	-247.43	-209.15	-141.63
Total Common Equity	76.31	70.01	52.38	37.14	-14.59	45.18
Minority Interest	22.62	23.99	32.64	18.81	19.15	19.37
Shareholders' Equity	98.93	93.99	85.02	55.95	4.56	64.56
Total Liabilities & Equity	452.07	442.03	441.46	346.29	302.57	402.65

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	189.76	165.79	152.35	114.61	116.04	113.7
Net Cash (Debt)	-119.66	-133.91	-86.63	-16.65	-73.65	-91.41
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.98	-1.10	-0.71	-0.14	-0.60	-0.74
Filing Date Shares Outstanding	121.41	121.78	121.78	121.78	121.78	121.78
Total Common Shares Outstanding	121.41	121.78	121.78	121.78	121.78	121.78
Working Capital	-46.34	-53.95	-63.67	-38.88	-97.09	-65.08
Book Value Per Share	0.63	0.57	0.43	0.30	-0.12	0.37
Tangible Book Value	69.77	63.38	45.68	29.72	-22.16	36.34
Tangible Book Value Per Share	0.57	0.52	0.38	0.24	-0.18	0.30
Buildings	-	107.1	107.1	107.1	107.1	117.62
Machinery	-	140.38	141.27	103.57	109	117.51
Construction In Progress	-	18.11	1.25	0.02	0.11	8.62

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error